1-1 of 1
Rui-Ping Dong
Close
Save search
Sort by
Journal Articles

A Phase II Study of ZD6474, a Vascular Endothelial Growth Factor Receptor (VEGFR) and Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients with Relapsed Multiple Myeloma (MM).

Free
Michael J. Kovacs, MD, FRCPC, Donna E. Reece, MD, FRCPC, Deborah Marcellus, MD, Ralph M. Meyer, MD, Sarah Matthews, MSc, Rui-Ping Dong, MD, PhD, Elizabeth Eisenhauer, MD, FRCPC
Journal: Blood
Blood (2004) 104 (11): 3464.
https://doi.org/10.1182/blood.V104.11.3464.3464
Published: 2004